Cyclerion Investor Webcast Event

Cyclerion-WebcastInvite

Learn more about praliciguat ahead of its two Phase 2 data readouts anticipated in Q4 2019.

Format

JPEG

Source

Cyclerion Therapeutics, Inc.

Téléchargements